SCHEMBL4786802

SCHEMBL4786802

Cc1nc(-c2cccc(Cl)c2)n(Cc2ccccc2)c1C(=O)NC(=N)N

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.47
HPGD P15428 2/20 0.47
KDM4E B2RXH2 1/20 0.47
GAA P10253 1/20 0.43
HTT P42858 1/20 0.43
TP53 P04637 2/20 0.43
MAPT P10636 1/20 0.43
TLR7 Q9NYK1 1/20 0.42
CNR2 P34972 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
MDM2 Q00987 1/20 0.40
AVPR1B P47901 3/20 0.39
CXCR2 P25025 1/20 0.39
CCR2 P41597 1/20 0.39
KLKB1 P03952 1/20 0.38
KLK1 P06870 1/20 0.38
PPARG P37231 1/20 0.38
PGR P06401 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4787412 0.92 TP53 (0.49) ALDH1A1HPGDGAAHTTTP53
SCHEMBL4786223 0.83 MAOB (0.46) ALDH1A1KDM4EHTTCNR2
SCHEMBL4786806 0.81 ALDH1A1 (0.48) ALDH1A1HPGDKDM4EGAAHTT
SCHEMBL4787618 0.73 CYP1A2 (0.47) ALDH1A1HPGDKDM4EGAAMAPT
SCHEMBL4787413 0.72 TP53 (0.51) ALDH1A1HPGDGAAHTTTP53
SCHEMBL4784399 0.72 RAB9A (0.38) ALDH1A1GAA
SCHEMBL17153358 0.71 CYP11B2 (0.46) ALDH1A1KDM4ETP53MAPTL3MBTL1
SCHEMBL28487655 0.70 ALDH1A1 (0.50) ALDH1A1HPGDKDM4EGAAHTT
SCHEMBL29411936 0.70 ALDH1A1 (0.50) ALDH1A1HPGDKDM4EGAAHTT
Hydrochloric Acid SCHEMBL8687192 0.69 CCR2 (0.57) CCR2PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008111794-A1 4-METHYLIMIDAZOL-5-YLCARBONYLGUANIDINE DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PREPARATION METHOD, AND PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF THE ISCHEMIC HEART DISEASES CONTAINING THE SAME AS AN ACTIVE INGREDIENT KOREA RESERACH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2008-09-18 WO disclosed